Pemvidutide Promising for Fatty Liver Disease Pemvidutide Promising for Fatty Liver Disease

Weight loss and multiple improvements in lipid parameters linked to nonalcoholic fatty liver disease were seen in a phase 1 trial.Medscape Medical News

Source: Medscape Gastroenterology Headlines - July 1, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news